Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 605
Recruiting: 316
Ph III recruiting: 30
Growth YoY: +37.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 1–17 of 17 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04866680	Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)(PERCIMEL)	active not recruiting	N/A	136	Institut de Cancérologie de LorraineOTHER	1	Sep 1, 2026	clinicaltrials
NCT07796594	Integration of Whole-Genome Sequencing PrOfiles and ImmuNe StATus in Cancer(SONATA)	active not recruiting	N/A	180	Amsterdam UMC, location VUmcOTHER	1	Sep 1, 2026